Cornerstone Pharmaceuticals announced on October 18, 2024, that it granted restricted shares to designated employees under the post-initial public offering Restricted Stock Award Plan and Employee Share Ownership Plan. The company issued 200,000 restricted share units to one eligible employee and a total of 6,280,000 stock options to three employees. The vesting period for the restricted share units exceeds 12 months and does not come with performance indicators. The exercise price of the stock options is HKD 1.76 per share, with a maximum exercise period of ten years. This initiative aims to recognize and reward employees for their contributions to the company, aligning with the interests of the company and shareholders to promote long-term growth.

Cornerstone Pharmaceuticals announced on October 18, 2024, that it granted restricted shares to designated employees under the post-initial public offering Restricted Stock Award Plan and Employee Share Ownership Plan. The company issued 200,000 restricted share units to one eligible employee and a total of 6,280,000 stock options to three employees. The vesting period for the restricted share units exceeds 12 months and does not come with performance indicators. The exercise price of the stock options is HKD 1.76 per share, with a maximum exercise period of ten years. This initiative aims to recognize and reward employees for their contributions to the company, aligning with the interests of the company and shareholders to promote long-term growth.